It would allow the buyers and sellers to get shares and money in their accounts one day after the trade takes place
Posts in category Business Standard
PSBs in focus; UCO Bank, Indian Overseas, Union Bank surge over 5% (16-01-2023)
Motilal Oswal Financial Services believes that sustained and consistent performance on delivering healthy return ratios can result in further re-rating of the stocks.
Sula Vineyards soars 10% on heavy volumes post Q3 sales update (16-01-2023)
The company said it recorded highest-ever quarterly gross billings overall, both for its own brands as well as wine tourism revenues in Q3FY23.
L&T Finance Holdings hits 52-week high, surges 6% on strong Q3 results (16-01-2023)
After the divestment of the mutual fund business, LTFH has proposed merger of its subsidiary lending entities – L&T Finance and L&T Infra Credit with itself
Avenue Supermarts slips 6%, hits over 6-month low post Q3 results (16-01-2023)
In Q3FY23, earnings before interest, taxes, depreciation, and amortization margins declined by 100 bps YoY to 8.6 per cent from 9.6 per cent in Q3FY22
Nifty Auto, Metal indices trading in thin range; here’s how to play them (16-01-2023)
The best trading strategy Nifty Auto index would be to sell near resistance levels until we get close above new high
Gold prices rise by Rs 10; yellow metal selling at Rs 52,000 per 10 grams (16-01-2023)
Silver price remained unchanged from yesterday’s close; the precious metal is selling at Rs 72,750 per kg
MARKET LIVE: Steady start likely ahead of WPI data; HDFC Bk, Wipro in focus (16-01-2023)
Stock market LIVE updates: Wholesale inflation data for the month of December will provide further direction to the markets
Stocks to Watch: Wipro, HDFC Bank, DMart, Delhivery, NDTV, Sula Vineyard (16-01-2023)
Stocks to Watch today: Wipro, after market hours on Friday, reported a consolidated net profit of Rs 3,052 crore for October-December FY23, an increase of 2.8 per cent year-on-year (YoY)
Breather for Natco in Novartis cardiac drug case from Delhi High Court (15-01-2023)
May open floodgates for Indian drugmakers to launch the generic version of the drug as early as next week